Novel heterocyclic quinoline/quinolone-based compounds as acetylcholinesterase inhibitors and antioxidant agents
Alzheimer’s disease represents about 60-80% of all cases of dementia, mainly affecting people over 65 years. This pathology is caracterizated at the molecular level by the presence of senile plaques (Aβ amyloid peptides aggregates) and neurofibrillary tangles (NFTs). In addition, several experimenta...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2019
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10773/30140 |
| País: | Portugal |
| Oai: | oai:ria.ua.pt:10773/30140 |